ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VVM Vivomedica

0.10
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vivomedica LSE:VVM London Ordinary Share GB0030475106 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.10 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Result of AGM

08/09/2008 10:53am

UK Regulatory


    RNS Number : 9250C
  Vivomedica PLC
  08 September 2008
   

 For immediate release  8 September 2008

    VivoMedica plc
    ("VivoMedica" or the "Company")

    Annual General Meeting Result

    VivoMedica plc (AIM:VVM) the pharmaware company, announces that all the resolutions were duly passed at the Company's Annual General
Meeting held today.

    A summary of proxy votes for each Resolution is below.

    
 Resolution                                               Percentage Votes For
 1. To receive and adopt the financial statements for                    99.6%
 the year ended 31 December 2007
 2. To re-appoint KPMG Audit Plc as Auditors of the                      99.9%
 Company
 3. To re-elect, as a Director, Peter Leyland                            98.7%
 4. To re-elect, as a Director, Alan Edwards                             98.7%
 5. To re-elect, as a Director, Susan Veness                             98.6%
 6. To authorise the Directors to allot relevant                         97.6%
 securities
 7. That the Directors be generally empowered pursuant                   96.5%
 to Section 95 of the Act to allot equity securities



    For further information, please contact:

    
 VivoMedicaPeter Leyland, Chief Executive OfficerSusan Veness,    01795 414460
 Finance Director
                                                                              
 Brewin Dolphin Investment Banking (NOMAD)Mark Brady / Alison    0845 270 8600
 Barrow
                                                                              
 Buchanan CommunicationsTim Anderson / Catherine Breen           020 7466 5000
                                                                              



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
RAGKGGGLLRGGRZG

1 Year Vivomedica Chart

1 Year Vivomedica Chart

1 Month Vivomedica Chart

1 Month Vivomedica Chart

Your Recent History

Delayed Upgrade Clock